tranexamic acid has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, K; Kozar, RA; LeBlanc, A; Peng, Z | 1 |
| Feng, C; Gao, Y; Jin, H; Li, T; Liu, Y; Teng, Y | 1 |
2 other study(ies) available for tranexamic acid and mocetinostat
| Article | Year |
|---|---|
Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock.
Topics: ADAM17 Protein; Animals; Enzyme-Linked Immunosorbent Assay; Inflammation; Intestinal Mucosa; Intestine, Small; Lung Injury; Male; Mice; Mice, Inbred C57BL; Peroxidase; Shock, Hemorrhagic; Syndecan-1; Tranexamic Acid; Tumor Necrosis Factor-alpha | 2016 |
Anti-inflammatory effect of tranexamic acid against trauma-hemorrhagic shock-induced acute lung injury in rats.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; DNA; Infusions, Intravenous; Interleukin-6; Lung; Male; Molecular Targeted Therapy; Neoplasm Proteins; NF-kappa B; Nucleocytoplasmic Transport Proteins; Peroxidase; Poly (ADP-Ribose) Polymerase-1; Protein Binding; Rats, Sprague-Dawley; Shock, Hemorrhagic; Signal Transduction; Tranexamic Acid; Tumor Necrosis Factor-alpha; Wounds and Injuries | 2018 |